We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: Through the collaboration with SouthGenetics, healthcare professionals across Latin America and the Caribbean will gain access to C2N’s Precivity portfolio of blood tests

Partnership Expands Access to Alzheimer’s Blood Tests in Latin America and Caribbean

C2N Diagnostics and SouthGenetics have partnered to expand access to Precivity blood tests for Alzheimer’s disease assessment across Latin America and the Caribbean. More...
02 Jun 2026
Image: Image: Findings showed that TP53 mutations correlate with lung cancer prognosis and may help guide therapy selection(image credit: Adobe Stock)

Tumor Mutation Marker Helps Refine Lung Cancer Prognosis and Guide Therapy Selection

New data show TP53 mutations in lung cancer predict poorer prognosis and guide selection between EGFR therapy and chemotherapy. More...
02 Jun 2026
PATHFINDER 2 Study: Screen Detected Cancers (Photo courtesy of GRAIL)

Multi-Cancer Test Boosts Detection When Added to Standard Screening

PATHFINDER 2 study findings show that GRAIL’s Galleri MCED test increased cancer detection 6.5-fold when added to recommended cancer screening. More...
02 Jun 2026
Image: Findings show that MRD‑guided intervention demonstrated the potential to delay or possibly prevent leukemic relapse (image credit: Shutterstock)

Blood-Based MRD Monitoring Supports Relapse Prevention in Leukemia

New long-term data show MRD-triggered therapy may delay or prevent relapse in MDS and AML. More...
01 Jun 2026
Image: The Decipher Prostate test can guide treatment decisions in metastatic prostate cancer (Photo courtesy of Veracyte)

Genomic Test Predicts Chemotherapy Benefit in Metastatic Prostate Cancer

New data show a genomic test predicts which metastatic prostate cancer patients benefit from triplet therapy. More...
01 Jun 2026
Image: New research shows that autoimmunity drives debilitating long COVID symptoms in a subset of patients (Image credit: Shutterstock)

Study Points to Autoimmune Pathway Behind Long COVID Symptoms

New findings show autoantibodies drive a long COVID subset marked by new-onset pain, guiding targeted immunotherapies. More...
01 Jun 2026
Image: Foundation Medicine will launch advanced digital solutions integrated with Roche’s navify Clinical Hub to deliver personalized insights to U.S. providers at the point of care (Photo courtesy of Roche)

AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines

An AI-enabled system links lab-sourced tumor profiling with trial matching and guideline mapping to speed treatment decisions. More...
01 Jun 2026
Visit expo >
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Immunofluorescence Analyzer
IFA System
Benchtop Thermomixer
Biometra TS1 ThermoShaker

In Other News

Copyright © 2000 - 2026 Globetech Media.
All rights reserved.
ADLM